The DOI matches its Crossref record.
Purification and physico-chemical characterization of rabbit tumor necrosis factor.
Abstract
Rabbit TNF has been purified 2000-fold by a series of salt precipitations, gel filtrations, ion exchange chromatography, and lectin affinity chromatography to a single species on SDS-polyacrylamide gel electrophoresis (SDS-PAGE). TNF activity could be recovered from nondenaturing gel systems and has been shown to be an alpha-globulin with an isoelectric point of 5.1. The m.w. was estimated to be 68,000 d by SDS-PAGE, 55,000 by gel filtration, and 52,000 by glycerol gradient centrifugation. TNF activity was stable over the pH range of 6 to 10 and was relatively heat stable, not being inactivated at 70 degrees C for 1 hr. TNF activity was pronase sensitive, but relatively trypsin resistant. Neuraminidase and phospholipase C treatment did not destroy TNF activity. Partially purified TNF was still capable of eliciting hemorrhagic necrosis in susceptible tumors. Crude TNF serum had an interferon titer of 3000 U, whereas the partially purified sample had a titer of <30 U.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Human tumor necrosis factor. Production, purification, and characterization.
Aggarwal, B. B., Kohr, W. J., Hass, P. E., Moffat, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89560-6 · Cited by 921
Tumor Necrosis Factor and Disease Severity in Children with Falciparum Malaria
Grau, G. E., Taylor, T. E., Molyneux, M. E., Wirima, J. J., Vassalli, P., Hommel, M., & Lambert, P.-H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906153202404 · Cited by 842
Sedger, L. M., & McDermott, M. F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.016 · Cited by 771
Comparison of in vitro cell cytotoxic assays for tumor necrosis factor
Flick, D. A., & Gifford, G. E. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90147-9 · Cited by 745
Self-citationTumor Necrosis Factor (Cachectin) as an Essential Mediator in Murine Cerebral Malaria
Grau, G. E., Fajardo, L. F., Piguet, P.-F., Allet, B., Lambert, P.-H., & Vassalli, P. (1987) · Science · doi:10.1126/science.3306918 · Cited by 736
Nawroth, P. P., Bank, I., Handley, D., Cassimeris, J., Chess, L., & Stern, D. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1363 · Cited by 693
Production of tumor necrosis factor-alpha by microglia and astrocytes in culture
Sawada, M., Kondo, N., Suzumura, A., & Marunouchi, T. (1989) · Brain Research · doi:10.1016/0006-8993(89)90078-4 · Cited by 631
Molecular Cloning of the Complementary DNA for Human Tumor Necrosis Factor
Wang, A. M., Creasey, A. A., Ladner, M. B., Lin, L. S., Strickler, J., Van Arsdell, J. N., Yamamoto, R., & Mark, D. F. (1985) · Science · doi:10.1126/science.3856324 · Cited by 622
Mathison, J. C., Wolfson, E., & Ulevitch, R. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113540 · Cited by 591
Piguet, P. F., Grau, G. E., Allet, B., & Vassalli, P. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1280 · Cited by 584
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583
Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure
Ferrari, R., Bachetti, T., Confortini, R., Opasich, C., Febo, O., Corti, A., Cassani, G., & Visioli, O. (1995) · Circulation · doi:10.1161/01.cir.92.6.1479 · Cited by 536
Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor
Shirai, T., Yamaguchi, H., Ito, H., Todd, C. W., & Wallace, R. B. (1985) · Nature · doi:10.1038/313803a0 · Cited by 459
Williamson, B. D., Carswell, E. A., Rubin, B. Y., Prendergast, J. S., & Old, L. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5397 · Cited by 456
Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis
Piguet, P. F., Collart, M. A., Grau, G. E., Sappino, A.-P., & Vassalli, P. (1990) · Nature · doi:10.1038/344245a0 · Cited by 454
Sherry, B., & Cerami, A. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.4.1269 · Cited by 432
The active form of tumor necrosis factor is a trimer.
Smith, R. A., & Baglioni, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48183-5 · Cited by 429
Grau, G. E., Heremans, H., Piguet, P. F., Pointaire, P., Lambert, P. H., Billiau, A., & Vassalli, P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5572 · Cited by 318
Luteolin as an Anti-inflammatory and Anti-allergic Constituent of Perilla frutescens.
Ueda, H., Yamazaki, C., & Yamazaki, M. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1197 · Cited by 290
Ferran, C., Sheehan, K., Dy, M., Schreiber, R., Merite, S., Landais, P., Noel, L., Grau, G., Bluestone, J., Bach, J., et al. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200308 · Cited by 264
Kawahara, K., Tsukano, H., Watanabe, H., Lindner, B., & Matsuura, M. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.4092-4098.2002 · Cited by 246
“TNF- was determined by a cytotoxic assay with L-929 cells (33).”
MethodMunger, M. A., Johnson, B., Amber, I. J., Callahan, K. S., & Gilbert, E. M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89206-5 · Cited by 237
Metadata
- Authors
- Ruff, M. R., & Gifford, G. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1980-10-01
- Volume
- 125
- Issue
- 4
- Pages
- 1671-1677
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1572295857
- Cited by
- 385
- References
- 0
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.